Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Yang

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Respiratory Cell and Molecular Biology|March 17, 2021
Targeting the AXL Receptor in Combating Smoking-related Pulmonary FibrosisDavid C Yang, Shenwen Gu, Ji-Min Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2021
Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosisJi-Min Li, David C Yang, Justin Oldham, et al.
Respiratory Research|May 16, 2023
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosisJi-Min Li, Wen-Hsin Chang, Linhui Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2019
Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progressionDavid C Yang, Ji-Min Li, Jihao Xu, et al.
Experimental Biology and Medicine (Maywood, N.J.)|October 27, 2009
The cellular and molecular immune response of the weanling piglet to staphylococcal enterotoxin BShuguang Bi, Rina Das, Elzbieta Zelazowska, et al.
Theranostics|March 23, 2021
MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancerJun Liu, Szu-Jung Chen, Ssu-Wei Hsu, et al.
Chemical Communications (Cambridge, England)|February 16, 2019
Rapid nickel(ii)-promoted cysteine S-arylation with arylboronic acidsKengo Hanaya, Jun Ohata, Mary K Miller, et al.
European Journal of Pharmacology|August 15, 2025
Repurposing flavopiridol as an inhaled therapeutic for pulmonary fibrosisChing-Hsien Chen, Subash K Chaudhary, Wen-Hsin Chang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 9, 2015
Trends in hospital treatments for peripheral arterial disease in the United States and association between payer status and quality of care/outcomes, 2007-2011Luke K Kim, Rajesh V Swaminathan, Robert M Minutello, et al.
Journal of the American College of Cardiology|March 28, 2015
Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data RegistryRajesh V Swaminathan, Sunil V Rao, Lisa A McCoy, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Respiratory Cell and Molecular Biology|March 17, 2021
Targeting the AXL Receptor in Combating Smoking-related Pulmonary FibrosisDavid C Yang, Shenwen Gu, Ji-Min Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2021
Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosisJi-Min Li, David C Yang, Justin Oldham, et al.
Respiratory Research|May 16, 2023
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosisJi-Min Li, Wen-Hsin Chang, Linhui Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2019
Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progressionDavid C Yang, Ji-Min Li, Jihao Xu, et al.
Experimental Biology and Medicine (Maywood, N.J.)|October 27, 2009
The cellular and molecular immune response of the weanling piglet to staphylococcal enterotoxin BShuguang Bi, Rina Das, Elzbieta Zelazowska, et al.
Theranostics|March 23, 2021
MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancerJun Liu, Szu-Jung Chen, Ssu-Wei Hsu, et al.
Chemical Communications (Cambridge, England)|February 16, 2019
Rapid nickel(ii)-promoted cysteine S-arylation with arylboronic acidsKengo Hanaya, Jun Ohata, Mary K Miller, et al.
European Journal of Pharmacology|August 15, 2025
Repurposing flavopiridol as an inhaled therapeutic for pulmonary fibrosisChing-Hsien Chen, Subash K Chaudhary, Wen-Hsin Chang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 9, 2015
Trends in hospital treatments for peripheral arterial disease in the United States and association between payer status and quality of care/outcomes, 2007-2011Luke K Kim, Rajesh V Swaminathan, Robert M Minutello, et al.
Journal of the American College of Cardiology|March 28, 2015
Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data RegistryRajesh V Swaminathan, Sunil V Rao, Lisa A McCoy, et al.
Pageof 3